KRAS and lung adenocarcinoma: Asian patients with stage IB lung adenocarcinoma are predominantly Epidermal growth factor receptor (EGFR) mutated and exhibit better prognosis, whereas Caucasian populations show higher prevalence of Kirsten rat sarcoma viral oncogene homolog (K-ras) mutations [24–26].